Screener
Sarepta Therapeutics, Inc. SRPT Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
FAQ
- What is Sarepta Therapeutics, Inc.'s total costs & expenses?
- Sarepta Therapeutics, Inc. (SRPT) reported total costs & expenses of $387.96M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s total costs & expenses changed year-over-year?
- Sarepta Therapeutics, Inc.'s total costs & expenses decreased by 21.7% year-over-year, from $495.51M to $387.96M.
- What does total costs & expenses mean?
- Total costs & expenses
Ask your AI about Sarepta Therapeutics, Inc.'s total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude